Synergistic activation of NF-κB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKβ-IκBα, and p38 MAPK
Creators
- 1. Gonda Department of Cell and Molecular Biology, House Ear Institute, University of Southern California, Los Angeles, CA 90057 (United States)
- 2. Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642 (United States)
- 3. Department of Microbiology, University of Minnesota Medical School, Minneapolis, MN 55455 (United States)
- 4. Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801 (United States)
- 5. Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642 (United States) and Gonda Department of Cell and Molecular Biology, House Ear Institute, University of Southern California, Los Angeles, CA 90057 (United States)
Description
In review of the past studies on NF-κB regulation, most of them have focused on investigating how NF-κB is activated by a single inducer at a time. Given the fact that, in mixed bacterial infections in vivo, multiple inflammation inducers, including both nontypeable Haemophilus influenzae (NTHi) and Streptococcus pneumoniae, are present simultaneously, a key issue that has yet to be addressed is whether NTHi and S. pneumoniae simultaneously activate NF-κB and the subsequent inflammatory response in a synergistic manner. Here, we show that NTHi and S. pneumoniae synergistically induce NF-κB-dependent inflammatory response via activation of multiple signaling pathways in vitro and in vivo. The classical IKKβ-IκBα and p38 MAPK pathways are involved in synergistic activation of NF-κB via two distinct mechanisms, p65 nuclear translocation-dependent and -independent mechanisms. Moreover, casein kinase 2 (CK2) is involved in synergistic induction of NF-κB via a mechanism dependent on phosphorylation of p65 at both Ser536 and Ser276 sites. These studies bring new insights into the molecular mechanisms underlying the NF-κB-dependent inflammatory response in polymicrobial infections and may lead to development of novel therapeutic strategies for modulating inflammation in mixed infections for patients with otitis media and chronic obstructive pulmonary diseases
Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2006.10.052;
- PII
- S0006-291X(06)02261-3;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 351
- Journal Issue
- 2
- Journal Page Range
- p. 368-375
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 38030095
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- CASEIN; HAEMOPHILUS; IN VITRO; IN VIVO; INFLAMMATION; PHOSPHORYLATION; RESPIRATORY SYSTEM DISEASES; REVIEWS; STREPTOCOCCUS; TRANSLOCATION
- Descriptors DEC
- BACTERIA; CHEMICAL REACTIONS; DISEASES; DOCUMENT TYPES; MICROORGANISMS; ORGANIC COMPOUNDS; ORGANIC PHOSPHORUS COMPOUNDS; PATHOLOGICAL CHANGES; PROTEINS; SYMPTOMS
Optional Information
- Copyright
- Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.